The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version

Ali Montazeri¹^,2 , Mariam Vahdaninia¹ , Mandana Ebrahimi² and Soghra Jarvandi²

¹Iranian Institute for Health Sciences Research

²Iranian Centre for Breast Cancer (ICBC)

author email corresponding author email

Health and Quality of Life Outcomes 2003, 1:14doi:10.1186/1477-7525-1-14


Published:	28 April 2003

Abstract

Background

The Hospital Anxiety and Depression Scale (HADS) is a widely used instrument to measure psychological morbidity in cancer patients. This study aimed to translate and test the reliability and validity of the Iranian version of the HADS.

Methods

The English language version of the HADS was translated into Persian (Iranian language) and was used in this study. The questionnaire was administered to a consecutive sample of 167 breast cancer patients and statistical analysis was performed to test the reliability and validity of the HADS.

Results

In general the Iranian version of the HADS was found to be acceptable to almost all patients (99%). Cronbach's alpha coefficient (to test reliability) has been found to be 0.78 for the HADS anxiety sub-scale and 0.86 for the HADS depression sub-scale. Validity as performed using known groups comparison analysis showed satisfactory results. Both anxiety and depression sub-scales discriminated well between sub-groups of patients differing in clinical status as defined by their disease stage.

Conclusion

This preliminary validation study of the Iranian version of the HADS proved that it is an acceptable, a reliable and valid measure of psychological distress among cancer patients.